ESR1 and neoplasm: To have the same patients included in comparisons across assessment methods, all further examinations were restricted to the group of 345 patients who had both ER and PgR assessed by both qPCR and IHC; 101 (29%) of these patients had tumours with no IHC stain for ER or PgR.